Gridai Technologies Corp (GRDX)

Dec 09, 2025

Entero Regains Nasdaq Compliance With Grid AI Acquisition - Monroe Evening News

Dec 09, 2025

Dec 09, 2025

GridAI Technologies Corp. Announces Appointment of Marshall Chapin as Chief Executive Officer of wholly-owned operating subsidiary GridAI, Inc - Black Hills Pioneer

Dec 09, 2025

Dec 07, 2025

Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX" - Lohud

Dec 07, 2025

Dec 05, 2025

GridAI Technologies Announces Board Changes and Rebranding - The Globe and Mail

Dec 05, 2025

Dec 05, 2025

GridAI appoints Marshall Chapin as CEO of energy-orchestration subsidiary - Yahoo Finance

Dec 05, 2025

Dec 04, 2025

GridAI Technologies Corp. Announces Board and Committee Changes - marketscreener.com

Dec 04, 2025

Dec 04, 2025

GridAI Technologies Corp. Appoints Marshall Chapin as Chief Executive Officer of wholly-owned operating subsidiary GridAI, Inc - marketscreener.com

Dec 04, 2025

Dec 04, 2025

GridAI Technologies (NASDAQ: GRDX) taps Marshall Chapin to lead AI data-center grid unit - Stock Titan

Dec 04, 2025

Nov 28, 2025

Entero Therapeutics Stock Gains 5% Ahead Of Name Change To GridAI - Nasdaq

Nov 28, 2025

Nov 28, 2025

Entero Therapeutics Stock Jumps After Company Rebrands As GridAI Technologies Corp. - MSN

Nov 28, 2025

Nov 28, 2025

Entero Therapeutics (ENTO) to Rebrand as GridAI (GRDX) Technologies - GuruFocus

Nov 28, 2025

Nov 28, 2025

Entero Therapeutics to Change Name to GridAI Technologies - marketscreener.com

Nov 28, 2025

Nov 28, 2025

Entero Therapeutics stock rises ahead of name change to GridAI By Investing.com - Investing.com South Africa

Nov 28, 2025

Nov 28, 2025

Entero Therapeutics stock rises ahead of name change to GridAI - Investing.com India

Nov 28, 2025

Nov 19, 2025

Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy - Greenville Online

Nov 19, 2025

Nov 19, 2025

Entero (NASDAQ: ENTO) Grid AI LOI with First Hyperscaler AI Data-Center Client - Stock Titan

Nov 19, 2025

Nov 16, 2025

Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid - St. Cloud Times

Nov 16, 2025

Nov 14, 2025

Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid - Record Searchlight

Nov 14, 2025

Nov 13, 2025

Entero Therapeutics (NASDAQ: ENTO) to name U.S. CEO and Executive Chairman for Grid AI - Stock Titan

Nov 13, 2025

Oct 30, 2025

Entero Therapeutics (NASDAQ: ENTO) acquires 100% of Grid AI, regains Nasdaq compliance - Stock Titan

Oct 30, 2025

Oct 14, 2025

$2.5B market opportunity: Entero Therapeutics acquires GRID AI to scale grid orchestration - Stock Titan

Oct 14, 2025

Oct 01, 2025

ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand - Yahoo Finance

Oct 01, 2025

Aug 14, 2025

Entero Therapeutics Plans 1:3 Reverse Split as Shares Drop Below Nasdaq Minimum - Stock Titan

Aug 14, 2025

Aug 11, 2025

Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules - Stock Titan

Aug 11, 2025

Mar 07, 2025

Entero Therapeutics, Inc. Chief Financial Officer Changes - marketscreener.com

Mar 07, 2025

Feb 14, 2025

Entero Therapeutics Appoints Richard Paolone as CEO - marketscreener.com

Feb 14, 2025

Feb 07, 2025

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members - marketscreener.com

Feb 07, 2025

Jan 26, 2025

Entero Therapeutics, Inc. announced that it has received $2 million in funding from 1396974 B.C. Ltd - marketscreener.com

Jan 26, 2025

Nov 27, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAF, ATSG, ENTO, AVTE on Behalf of Shareholders - marketscreener.com

Nov 27, 2024

Nov 14, 2024

Entero Therapeutics CEO James Sapirstein to Moderate the 2024 BioFlorida Annual Innovation Conference CEO Forum - marketscreener.com

Nov 14, 2024

Nov 13, 2024

Entero Therapeutics Announces 99% Reverse Merger Deal with Journey's Cancer Platform - Stock Titan

Nov 13, 2024

Nov 12, 2024

Journey Therapeutics, Inc. entered into a binding term sheet to acquire Entero Therapeutics, Inc. in a reverse merger transaction. - marketscreener.com

Nov 12, 2024

Sep 10, 2024

Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings - marketscreener.com

Sep 10, 2024

Aug 23, 2024

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q - marketscreener.com

Aug 23, 2024

Aug 01, 2024

Entero Therapeutics Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - marketscreener.com

Aug 01, 2024

Jul 31, 2024

Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - marketscreener.com

Jul 31, 2024

May 20, 2024

ENTOEntero Therapeutics Latest Stock News & Market Updates - Stock Titan

May 20, 2024

Apr 17, 2024

First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase - marketscreener.com

Apr 17, 2024

Apr 15, 2024

First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference - marketscreener.com

Apr 15, 2024

Jan 17, 2024

First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico - marketscreener.com

Jan 17, 2024